Elizabeth Philp
Chief Executive Officer and Co-Founder of Roseway Labs, a private pharmacy established in 2018 that collaborates with private doctors to deliver personalized medicine tailored to individual patient needs.
Roseway Labs
Founded in 2018, Roseway Labs aims to make compounded medication accessible to a broader population, providing personalized solutions for patients with special medical needs or those seeking hard-to-find medications. The pharmacy uniquely combines compounded medications with licensed and unlicensed medications, supplements, diagnostic kits, and clinical stock, offering an unparalleled breadth of services in the UK.
About Elizabeth
Elizabeth holds a BSc in Chemistry and Mathematics, an MSc in Organisational Behaviour, and an MBA from London Business School. Her career spans roles in human resources, management consultancy, and independent consulting, culminating in leadership positions within the healthcare sector. This diverse experience, coupled with her mentorship roles at the Prince’s Trust and London Business School, fueled her desire to establish Roseway Labs.
Beyond her professional endeavors, Elizabeth enjoys spending time with her young family and attending weekly sewing classes.
Elizabeth Philp’s Expertise in Personalised Compounded Medications
- Customized Hormone Solutions: Expert in delivering tailored Hormone Replacement Therapy (HRT) through compounded medications, ensuring precise dosages and formulations suited to each individual’s needs.
- Collaborative Approach: Works closely with healthcare providers to craft bespoke HRT solutions, ensuring that treatments align with a comprehensive care plan for the best possible outcomes.
- Specialist Treatments: Focuses on conditions that benefit from specialized medication, such as hormone imbalances, thyroid disorders, chronic pain, and dermatological issues. These treatments cater to specific health needs that mass-produced medications may not meet.
